Dexamethasone, Levofloxacin

Levodexa

0.1 % / W/V + 0.5 % / W/V SolutionCanadaMarketedAuthorised 21 Aug 2025

In other countries

The same active substances on other registers, the same brand first.

Ducressa®Serbia · 1mg/mL+5mg/mL · kapi za oči, rastvor · Medis Pharma D.O.O. BeogradSame form
Ducressa Eye Drops Solution 1MG/ML + 5MG/MLSingapore · 1.00mg/mL + 5.00mg/mL · solution, sterile · Santen Pharmaceutical Asia Pte. LTD.Same form
Ducressa 1 MG/ML + 5 MG/ML Colirio en SolucionSpain · 5,12 mg/ml + 1,32 mg/ml · colirio en solución · Santen OySame substance
Levendex 1 MG/ML + 5 MG/ML Colirio en SolucionSpain · 5,12 mg/ml + 1,32 mg/ml · colirio en solución · Ntc S.R.L.Same substance
Ducressa 1 mg/ml + 5 mg/ml kapi za oko, otopinaCroatia · kapi za oko, otopina · Santen Oy, Niittyhaankatu 20, Tampere, FinskaSame substance
Ducressa 1 mg/ml / 5 mg/ml, oogdruppels, oplossingNetherlands · Oogdruppels, oplossing · Santen Oy

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Dexamethasone, Levofloxacin

Levodexa

0.1 % / W/V + 0.5 % / W/V SolutionCanadaMarketedAuthorised 21 Aug 2025

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Dexamethasone, Levofloxacin
Strength: 0.1 % / W/V + 0.5 % / W/V
Dosage form: Solution
Route: Ophthalmic
Register: Canada (Health Canada)
Status: Marketed
Authorised: 21 Aug 2025
Registration: DIN 02543745
Marketing authorisation holder: Xediton Pharmaceuticals INC
ATC code: S01CA01
Group: Sensory organs
Supply: PRESCRIPTION